Perspectives

Whatever your opinion on peer review, impact factors or the current medical publication models, medical publications remain and should remain central to medical communications. Only by having data in the public domain in a transparent way can clinicians educate themselves on new data, changing trends and best practice. Medical education and marketing in healthcare relies on data and associated publications being high-quality and robust - regardless of whether the basis of a publication is data from a large-clinical trial, market research, from a registry or an individual case study.

Many have heard of Gestalt psychology and psychotherapy but few know what it is in any detail. Here at Lumanity we have begun to employ selective gestalt psychotherapeutic techniques to go beyond the revelations of projection.

No matter how robust in design, clinical trials can never fully address the uncertainty surrounding the comparative effectiveness and safety of a novel product in the real world.

US distributors and agents trying to import rapid antibody tests for coronavirus face a number of obstacles. The good news is that the FDA has opened up the Emergency Use Authorization (EUA) program to include SARS-CoV-2 (the virus) and COVID-19 (the disease), expediting time to market.